Joshua Benham, MD
Obstetrics/Gynecology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 13 years
- Perelman School of Med at the University of Pennsylvania, 2013
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Looking this up.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Benham’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A148739 · Current
Licensed to practise in California · since 2017 · expires 2028-11-30 · Perelman School of Medicine at the University of Pennsylvania.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
Drugs they prescribed that Part D paid
$2,096
Pharmacies billed $2,096 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 20) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
17 generic and fewer than 11 brand-name prescriptions · $2,096 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Alendronate | 11 | $165 | $15 |
Year by year
| 2024 | 20 | None | 0% (0) | None | $2,096 |
| 2023 | 14 | None | 0% (0) | None | $1,999 |
| 2022 | 20 | None | 0% (0) | None | $4,536 |
| 2021 | 13 | None | 0% (0) | None | $1,348 |
| 2020 | 19 | None | None | 0% | $1,171 |
| 2019 | 11 | None | 0% (0) | 0% | $476 |
| 2018 | 12 | None | 0% (0) | None | $3,787 |
| 2014 | 13 | 11 | 0% (0) | None | $2,318 |
| 2013 | 20 | None | 0% (0) | None | $1,318 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$497 in 2025
| 2025 | 10 | 17 | None | $497 |
| 2024 | 6 | 12 | None | $203 |
| 2023 | 6 | 10 | None | $344 |
| 2022 | 13 | 20 | None | $361 |
| 2021 | 15 | 23 | None | $463 |
| 2020 | 4 | 10 | None | $166 |
| 2019 | 1 | 1 | None | $116 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Millicent US | Femring | $127 | 3 payments
|
| Astellas Pharma US | Veozah | $88 | 4 payments
|
| Hologic Sales and Service | Myosure Tissue Removal Device | $55 | 1 payment
|
| Biogen | Zurzuvae | $55 | 2 payments
|
| CooperSurgical | Paragard T 380a | $38 | 2 payments
|
| Ethicon US | Dermabond Prineo | $35 | 1 payment
|
See all 17 published payments
| CooperSurgical | Meals · 2025-12-11 | Paragard T 380a | $17 |
| Octapharma USA | Meals · 2025-12-02 | Fibryga | $19 |
| Astellas Pharma US | Meals · 2025-11-18 | Veozah | $25 |
| Minerva Surgical | Meals · 2025-10-21 | None | $29 |
| Biogen | Meals · 2025-10-16 | Zurzuvae | $25 |
| Astellas Pharma US | Meals · 2025-09-05 | Veozah | $28 |
| Shield Therapeutics | Meals · 2025-08-19 | Accrufer | $27 |
| Exact Sciences | Meals · 2025-07-29 | Cologuard Collection Kit | $23 |
| Biogen | Meals · 2025-07-28 | Zurzuvae | $30 |
| Millicent US | Meals · 2025-05-30 | Femlyv | $17 |
| Ethicon US | Meals · 2025-03-07 | Dermabond Prineo | $35 |
| Astellas Pharma US | Meals · 2025-03-03 | Veozah | $14 |
| CooperSurgical | Meals · 2025-02-28 | Paragard T 380a | $21 |
| Millicent US | Meals · 2025-01-29 | Femring | $20 |
| Millicent US | Education · 2025-01-29 | None | $90 |
| Astellas Pharma US | Meals · 2025-01-09 | Veozah | $21 |
| Hologic Sales and Service | Meals · 2025-01-07 | Myosure Tissue Removal Device | $55 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $203
| Millicent US | Femring | $79 | 4 payments
|
| Hologic Sales and Service | Aptima | $38 | 2 payments
|
| Organon | Nexplanon | $37 | 2 payments
|
| Amgen | Evenity | $21 | 1 payment
|
| Evofem Biosciences | None | $15 | 1 payment
|
| Mayne Pharma Commercial | None | $12 | 2 payments
|
2023: $344
| Myriad Women's Health | Myrisk | $204 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $45 | 2 payments
|
| Amgen | Evenity | $41 | 2 payments
|
| Astellas Pharma US | Veozah | $27 | 1 payment
|
| Medtronic | Truclear | $21 | 1 payment
|
| Mayne Pharma Commercial | None | $6 | 2 payments
|
2022: $361
| Abbvie | Lo Loestrin Fe | $80 | 4 payments
|
| Medicem | Dilapan-S | $32 | 2 payments
|
| CooperSurgical | Paragard | $31 | 2 payments
|
| Mayne Pharma | None | $29 | 2 payments
|
| Sage Therapeutics | Zulresso | $25 | 1 payment
|
| Organon | Nexplanon | $24 | 1 payment
|
| Evofem Biosciences | Phexxi | $23 | 1 payment
|
| Hologic | Aptima | $22 | 1 payment
|
| Channel Medsystems | None | $22 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Mirena | $21 | 1 payment
|
| Davol | Arista Ah Flexitip | $20 | 1 payment
|
| Pfizer | Premarin | $17 | 1 payment
|
| Aspira Women's Health | Ova1 | $15 | 1 payment
|
2021: $463
| AbbVie | Orilissa | $139 | 6 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $52 | 2 payments
|
| TherapeuticsMD | Annovera | $36 | 2 payments
|
| Amgen | Evenity | $31 | 1 payment
|
| Medicem | Dilapan-S | $28 | 2 payments
|
| CooperSurgical | Paragard | $23 | 1 payment
|
| Avanos Medical | On-Q* Pump and Accessories | $21 | 1 payment
|
| Becton Dickinson and | Bd Onclarity | $20 | 1 payment
|
| Merck Sharp & Dohme | Gardasil 9 | $19 | 1 payment
|
| ASCEND Therapeutics US | Estrogel | $18 | 1 payment
|
| Evofem Biosciences | Phexxi | $16 | 1 payment
|
| Mayne Pharma | None | $15 | 1 payment
|
| Mylan Pharmaceuticals | Xulane | $15 | 1 payment
|
| Pfizer | Premarin | $15 | 1 payment
|
| Agile Therapeutics | Twirla | $13 | 1 payment
|
2020: $166
| AbbVie | Oriahnn | $67 | 4 payments
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $46 | 3 payments
|
| TherapeuticsMD | Annovera | $39 | 2 payments
|
| Hologic | Thinprep | $15 | 1 payment
|
2019: $116
| AbbVie | Orilissa | $116 | 1 payment
|
Professional record
- NPI
- 1528406881
- Licence
- CA A148739, PA MT204983California A148739: Current · expires 2028-11-30
- Trained
- Perelman School of Med at the University of Pennsylvania, 2013 · 13 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X); Student in a training program (390200000X)
- Mailing address
- 1855 4th St, Fl 3, San Francisco, CA, 94143
- NPI first listed
- 2013-06-10
- NPI last updated
- 2020-07-13
- NPI record certified
- 2020-07-13
This is when the NPI record was last certified, not a medical board exam.